November 08, 2017
Nordic Nanovector: Protocol Amendment filed in the UK to enable initiation of Phase 2 PARADIGME
Media
November 07, 2017
Nordic Nanovector ASA (OSE: NANO) to host Capital Markets Day and Present Q3 Results on 22 November 2017 in Oslo
November 07, 2017
Targovax ASA: Notice of Extraordinary General Meeting
November 07, 2017
Strongbridge Biopharma plc to Present at the Stifel 2017 Healthcare Conference
November 06, 2017
Strongbridge Biopharma plc to Host Third Quarter 2017 Financial Results Conference Call on November 14, 2017
November 06, 2017
GenSight Biologics to Participate in Multiple Conferences in November
November 02, 2017
BONESUPPORT HOLDING AB (publ) – Interim Report – January – September 2017
November 02, 2017
Targovax Reports 2017 Third Quarter Financial Information
November 01, 2017
Oncopeptides to present data from two clinical studies of Ygalo® (melflufen) at American Society of Hematology (ASH), December 9-12
November 01, 2017
Nordic Nanovector: Updated results from Phase 1/2 trial of Betalutin® in non-Hodgkin lymphoma to be presented at ASH in December
